China’s clinical trials and efficacy data have been among the world’s most valuable in recent years, according to a new report.
Chinese doctors have been injecting hundreds of millions of doses of traditional Chinese medicine into a growing number of patients over the past decade, and have found that some treatments have shown clinical effectiveness in a fraction of the cases.
But the new report from the Chinese Academy of Sciences and the National University of Singapore paints a more nuanced picture of Chinese medicine’s success in the West.
The report, “The China Experience,” is the first comprehensive overview of Chinese clinical trials conducted in the U.S., China and the U,S.
and European Union.
The findings include a surprising trend in Chinese clinical trial data, where the overall efficacy of a drug was measured against a standard set of criteria, but not against the Chinese standard.
This meant that some drugs, particularly in China, could not be seen as particularly effective.
For example, in one Chinese trial, researchers injected patients with a drug called DMT, a psychedelic drug that is popular in the west, and found that the drug reduced the number of seizures in those who took it, but did not appear to have a significant effect on the number or severity of other symptoms.
The researchers found that in the same trial, the drug was not associated with a significant reduction in the rate of death.
The drug was also not associated, for example, with a decrease in the severity of the symptoms of people with diabetes or high blood pressure.
Researchers from the National Center for Biomedical Research and the Center for Disease Control and Prevention said the findings “are likely due to methodological weaknesses,” but that the results may not be a complete picture of the effectiveness of Chinese traditional medicine.
“We still need to better understand the underlying mechanisms of effectiveness and safety in these trials,” they said.
“A number of factors can influence the efficacy and safety of a given drug.
The study of efficacy in Chinese traditional and western medicine is one of the most important of these factors.”
The authors of the report also found that traditional Chinese medicines are not only safe, but effective at preventing serious adverse side effects.
In a number of cases, patients were given the drug as a single dose, with the result that they experienced no adverse effects or serious side effects, but the drugs also reduced the risk of developing certain serious side conditions.
The study’s authors said the data they gathered in China has “far-reaching implications for the efficacy of Chinese treatments and their potential for global benefit.”
The report also noted that the success of Chinese pharmacology is also being influenced by the availability of modern, cheaper drugs.
In the last two years alone, Chinese researchers have created more than 4,000 new drugs to combat a range of common medical conditions, including heart disease, diabetes and stroke, as well as arthritis, cancer, diabetes, and a range in the immune system.
A number a of these drugs have been approved for clinical use in the United States.